Abstract
Fast chiral liquid chromatographic methods are developed for the separation of bicalutamide and thalidomide enantiomers in bulk drug samples in an elution time of about 15 min. The chromatographic separation was carried out on various solvents using an amylose 3,5-dimethylphenylcarbamate immobilized onto silica gel (Chiralpak®-IA). The resolution (Rs) between the enantiomers is found to be greater than 1.5 in the developed method. Chiralpak®-IA column played a key role in achieving chromatographic resolution between the enantiomers and also in enhancing chromatographic efficiency. The columns compatability to non standard chromatographic solvents is checked and found suitable.
Keywords: Bicalutamide, Thalidomide, Chiralpak®-IA, Enantiomeric separation, Non-Steroidal Anti-Androgen, Sedative-Hypnotic, Multiple Myeloma, Pharmacokinetic, HPLC, Limit of Quantification, Precision, Robustness
Current Pharmaceutical Analysis
Title: Novel Chiral LC Methods for the Enantiomeric Separation of Bicalutamide and Thalidomide on Amylose Based Immobilized CSP
Volume: 7 Issue: 1
Author(s): I. V. Soma Raju, P. Raghuram and J. Sriramulu
Affiliation:
Keywords: Bicalutamide, Thalidomide, Chiralpak®-IA, Enantiomeric separation, Non-Steroidal Anti-Androgen, Sedative-Hypnotic, Multiple Myeloma, Pharmacokinetic, HPLC, Limit of Quantification, Precision, Robustness
Abstract: Fast chiral liquid chromatographic methods are developed for the separation of bicalutamide and thalidomide enantiomers in bulk drug samples in an elution time of about 15 min. The chromatographic separation was carried out on various solvents using an amylose 3,5-dimethylphenylcarbamate immobilized onto silica gel (Chiralpak®-IA). The resolution (Rs) between the enantiomers is found to be greater than 1.5 in the developed method. Chiralpak®-IA column played a key role in achieving chromatographic resolution between the enantiomers and also in enhancing chromatographic efficiency. The columns compatability to non standard chromatographic solvents is checked and found suitable.
Export Options
About this article
Cite this article as:
V. Soma Raju I., Raghuram P. and Sriramulu J., Novel Chiral LC Methods for the Enantiomeric Separation of Bicalutamide and Thalidomide on Amylose Based Immobilized CSP, Current Pharmaceutical Analysis 2011; 7 (1) . https://dx.doi.org/10.2174/157341211794708758
DOI https://dx.doi.org/10.2174/157341211794708758 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Withdrawal Notice: Preparation and Applications of Glyconanoparticles
Current Drug Targets Impaired Expression and Function of Cancer-Related Enzymes by Anthocyans: An Update
Current Enzyme Inhibition Scaffold-based Drug Delivery for Cartilage Tissue Regeneration
Current Pharmaceutical Design Vitamin D Receptor Agonists: Opportunities and Challenges in Drug Discovery
Current Topics in Medicinal Chemistry Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry 7-aa Peptide Mimic from HVR1 of HCV Protects Hepatic Injury in Rats by Reduced Expression of Key Pro-Inflammatory Factors
Inflammation & Allergy - Drug Targets (Discontinued) Benzimidazole Derivatives as Kinase Inhibitors
Current Medicinal Chemistry BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets Fabrication and Physicochemical and Medicinal Characterization of Nano Traditional Chinese Medicine
Recent Patents on Engineering Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Destination Penis? Gene Therapy as a Possible Treatment for Erectile Dysfunction
Current Gene Therapy Natural Products as Farnesoid X Receptor (FXR) Agonists: Their Interactions with FXR Ligand Binding Region
Mini-Reviews in Organic Chemistry Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Genome-Wide Analysis of Low Dose Bisphenol-A (BPA) Exposure in Human Prostate Cells
Current Genomics QSAR and the Prediction of T-Cell Epitopes
Current Proteomics Clinical PET Imaging of Insulinoma and Beta-Cell Hyperplasia
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews